【24h】

Lot-to-Lot Inconsistency of Anticardiolipin Reagents

机译:抗心磷脂试剂批对批不一致

获取原文
           

摘要

The diagnostic criteria for antiphospholipid syndrome include the presence of one or more typical clinical features plus one or more laboratory findings (1). The latter include positivity (on two or more occasions, ≥6 weeks apart) of either lupus anticoagulant or anticardiolipin antibody (ACA).We report inconsistencies among lots of anticardiolipin reagents from one supplier and suggest that the differences are related to changes in calibration materials that are also used by other suppliers of ACA reagents.Several, perhaps most, ACA ELISAs are calibrated with Harris “standards” (Louisville APL Diagnostics, Inc.) or secondary calibrators that are traceable to them. Recently, there has been a change in the latest generation of calibration materials, the LAPL-GM-200 calibrators for IgG and IgM ACA. When the latest LAPL-GM-200 calibrators were produced, the manufacturer attempted to make these new calibrators agree with …
机译:抗磷脂综合征的诊断标准包括一种或多种典型的临床特征以及一种或多种实验室检查结果(1)。后者包括狼疮抗凝药或抗心磷脂抗体(ACA)的阳性反应(两次或两次以上,相隔≥6周)。我们报告一家供应商提供的许多抗心磷脂药物之间存在不一致之处,并指出差异与校正材料的变化有关其他,也许大多数,ACA ELISA都使用哈里斯“标准”(Louisville APL Diagnostics,Inc.)或可追溯到它们的二级校准器进行了校准。最近,最新一代的校准材料(用于IgG和IgM ACA的LAPL-GM-200校准器)发生了变化。当生产最新的LAPL-GM-200校准器时,制造商试图使这些新的校准器与…保持一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号